| 0.9 |
2.7 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.9 |
2.6 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.9 |
11.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.8 |
2.4 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.6 |
1.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
1.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.5 |
1.6 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.5 |
1.5 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.5 |
1.8 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 |
1.3 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.4 |
1.7 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.4 |
1.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.4 |
0.8 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.4 |
5.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.4 |
1.5 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.4 |
1.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
1.1 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.3 |
1.0 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 |
1.0 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.3 |
1.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 |
1.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
2.2 |
GO:0045989 |
positive regulation of striated muscle contraction(GO:0045989) |
| 0.3 |
1.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
1.8 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 |
0.9 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.3 |
2.0 |
GO:0031652 |
positive regulation of heat generation(GO:0031652) |
| 0.3 |
1.9 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.3 |
0.8 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 |
1.0 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.3 |
2.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.3 |
0.8 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.3 |
2.5 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.3 |
0.8 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.2 |
1.0 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.2 |
1.0 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.2 |
1.6 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
1.9 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 |
0.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
2.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
0.9 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.7 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 |
1.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
2.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
0.8 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.2 |
0.8 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.2 |
1.0 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.2 |
3.5 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 |
1.7 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
0.6 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
0.9 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
0.9 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.2 |
0.9 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
1.2 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.2 |
0.8 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.2 |
0.6 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
1.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
0.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.9 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.4 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.1 |
0.4 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 |
1.2 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.1 |
0.6 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
0.9 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.5 |
GO:0072592 |
oxygen metabolic process(GO:0072592) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.5 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 |
0.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.7 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
0.2 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
1.8 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.5 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.6 |
GO:1902309 |
positive regulation of mast cell chemotaxis(GO:0060754) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
0.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
0.8 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.6 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.1 |
1.2 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.1 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.5 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.7 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
2.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.9 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.9 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
1.0 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.1 |
0.5 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
1.0 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.5 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.3 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
0.4 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.1 |
1.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.4 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.4 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
1.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
1.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
1.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
1.0 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.6 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.6 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
1.5 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.6 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.7 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.2 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.1 |
0.5 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.6 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.2 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
3.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.6 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.1 |
0.2 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.9 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.9 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.6 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 |
1.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.2 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.1 |
0.2 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.7 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
0.2 |
GO:1904749 |
protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
0.3 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.5 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
1.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
1.8 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.3 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
0.8 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.4 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
1.8 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 |
1.9 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.3 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.2 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
1.6 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.4 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.0 |
0.4 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.0 |
0.2 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.1 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.0 |
1.7 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.5 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.5 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.6 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.2 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.9 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.4 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.1 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.7 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
1.1 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
2.1 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.4 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.5 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.0 |
0.8 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.5 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.8 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.8 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.8 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.4 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 |
0.5 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.0 |
1.9 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.8 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.4 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.0 |
0.5 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 |
0.2 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.0 |
0.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.9 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.3 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
1.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.4 |
GO:1902742 |
apoptotic process involved in development(GO:1902742) |
| 0.0 |
0.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.5 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
0.1 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.0 |
0.1 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 |
1.2 |
GO:0007093 |
mitotic cell cycle checkpoint(GO:0007093) |
| 0.0 |
0.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.1 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.6 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.0 |
0.5 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.6 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.2 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.0 |
0.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.2 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
1.7 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.8 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.5 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.1 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.2 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.0 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
